DGNews
There is no particular increase in risk for patients with bilateral macular degeneration treated with bilateral injections of intravitreal anti-vascular endothelial growth factor inhibitors (VEGF), according to a study presented here at the Association for Research in Vision and Ophthalmology (ARVO) 2009 Annual Meeting.